Pharmacological Activation of cGAS for Cancer Immunotherapy

Kyle M. Garland(Vanderbilt University), John T. Wilson(Vanderbilt University)

Frontiers in Immunology

November 26, 2021

10.3389/fimmu.2021.753472

Cited by 24

Related Papers

STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy

|Science Immunology|2023|118

Multiparametric Single-Vesicle Flow Cytometry Resolves Extracellular Vesicle Heterogeneity and Reveals Selective Regulation of Biogenesis and Cargo Distribution

|ACS Nano|2024|52

EV Fingerprinting: Resolving extracellular vesicle heterogeneity using multi-parametric flow cytometry

|bioRxiv (Cold Spring Harbor Laboratory)|2022|3